Study lung changes before and after treatment for active TB
Part of Immune system & allergy, Infections clinical trials.
This study looks at changes in the lungs and immune system before TB treatment and again after treatment. By sampling lung fluid and comparing it over time, researchers hope to learn signatures that reflect how TB responds to care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 60 years old.
- Have active tuberculosis in only one lung (unilateral TB).
- Have not started TB treatment yet, and no strong signs of past TB on scans.
- Be able and willing to have research bronchoscopy (a procedure to collect lung samples) at baseline, 6 months, and 18 months.
- If living with HIV, you must have been stable on HIV treatment (antiretroviral therapy) for at least 1 year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a lung rehabilitation program (like physical therapy for your lungs) can help people who recently started TB treatment breathe and feel better. You need a smartphone and must be willing to attend sessions for 48 weeks.
This trial studies whether atorvastatin (a cholesterol medicine) can reduce ongoing inflammation after you finish standard tuberculosis (TB) treatment. If it works, it may improve how your body recovers after TB, especially by lowering inflammation-related signals.
This study looks at your lung health and overall wellbeing after finishing treatment for tuberculosis (TB). It aims to understand how TB affects breathing and quality of life, so doctors can better support recovery.
This study looks at how the immune system and natural germs in the lungs work in people who have recently been in close contact with someone with active tuberculosis (TB). It aims to better understand how the body responds to TB exposure.
This study looks at how the immune system reacts in people with tuberculosis (TB), their close contacts, people with other lung diseases, and healthy volunteers. It aims to find better ways to diagnose and manage TB.
This study tests whether two medicines, metformin and N-acetylcysteine, can help your lungs heal better after tuberculosis (TB). You will receive one of these study drugs along with your regular TB treatment.
Hear when a new HIV/AIDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.